Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.

De Hert, Marc, Detraux, Johan, van Winkel, Ruud, Yu, Weiping, Correll, Christoph U.·2012·Nature Reviews Endocrinology

DOI 10.1038/nrendo.2011.156

Cited by (1,000)

Items 601–700 of 1,000

Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats
Dandan Tian, Wei Wang, Huaning Wang, Stephen Cho Wing Sze, Zhang-Jin Zhang · 2016 · Molecules
Weight Gain and Antipsychotics. Data from EUFEST Study
Valentin Petre Matei · 2016 · Acta Endocrinologica (Bucharest)
Possible impact of ADRB3 Trp64Arg polymorphism on BMI in patients with schizophrenia
Daimei Sasayama, Hiroaki Hori, Toshiya Teraishi, Kotaro Hattori, Miho Ota, Masahiko Tatsumi, Teruhiko Higuchi, Naoji Amano, Hiroshi Kunugi · 2012 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Interplay between negative symptoms, time spent doing nothing, and negative emotions in patients with schizophrenia spectrum disorders: results from a 37-site study
Giulio D’Anna, Cristina Zarbo, Giuseppe Cardamone, Manuel Zamparini, Stefano Calza, Matteo Rota, Christoph Ulrich Correll, Matteo Rocchetti, Fabrizio Starace, Giovanni de Girolamo et al. · 2023 · Schizophrenia
Cardiometabolic adverse effects of long-term antipsychotic treatment in children and adolescents with non-psychotic disorders: a systematic review of available evidence
Ramya Padmavathy Radha Krishnan, Monika Dzidowska, Danni Zheng, Zoie Shui-Yee Wong, Nicholas Allan Buckley, Jacques Raubenheimer · 2025 · European Child & Adolescent Psychiatry
Diabetes mellitus onset in geriatric patients: does long‐term atypical antipsychotic exposure increase risk?
Roza Abitbol, Soham Rej, Marilyn Segal, Karl Julian Looper · 2014 · Psychogeriatrics
Effects of the First Exposure of Antipsychotics on Serum Albumin in Adolescents and Young Adults With First-Episode Schizophrenia
Desheng Zhai, Yijun Liu, Fengchun Ma, Yihang Feng, Zhong-Jie Xu, Taizhen Cui, Lang Yan, Xin Wang, Ying Cao, Ying Y. Zhao et al. · 2017 · Journal of Clinical Psychopharmacology
Metformin Attenuates Liver Fat Content: Finding from Schizophrenia Patients with Olanzapine-induced Weight Gain
Li Wang, Yu Chen, Yunchuan Sui, Xingqi Tan, Zhi Zhou, Ning Li, Le-ping Xu · 2020 · Clinical Psychopharmacology and Neuroscience
Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study
Preeya J. Patel, Christian Weidenfeller, Andrew P. Jones, Jens Nilsson, Jay Hsu · 2020 · Neurology and Therapy
Magnitude of metabolic syndrome and its predictors among patients on second-generation antipsychotic drugs at six psychiatry clinics and mental hospitals, in Addis Ababa, Ethiopia, 2019; Multicenter cross-sectional study
Getasew Amogne, Tadesse Alemu, Trhas Tadesse, Assefa Mullu · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
Association of cardiovascular metabolic risk factor measurements with psychiatric readmission among in-hospital patients with severe mental illness: a retrospective study
Xiao Wei Tan, Christopher Yi Wen Chan, Alvin Lum, Eng Sing Lee, Yee Ming Mok, Daniel S S Fung, Phern Chern Tor · 2022 · BMC Psychiatry
A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects
Mikołaj Matłoka, Sylwia Janowska, Piotr Pankiewicz, Sofiya Kokhanovska, Tomasz Kos, Małgorzata Hołuj, Izabela Rutkowska-Włodarczyk, Krzysztof Marek Abramski, Monika Janicka, Piotr Jakubowski et al. · 2022 · Frontiers in Pharmacology
A mixed-methods review and meta-synthesis of fears of recurrence and progression in people with mental health conditions
Daelin Coutts‐Bain, Louise Sharpe, Pirathat Techakesari, Madeline Anne Forrester, Caroline Jane Hunt · 2023 · Clinical Psychology Review
The risk of stroke and post-stroke mortality in people with schizophrenia: A systematic review and meta-analysis study
Ryan Sai Ting Chu, Ryan Chi Hin Chong, Don Ho Hin Chang, Alice Lok Shan Leung, Joe Kwun Nam Chan, Corine Sau Man Wong, Wing Chung Chang · 2024 · Psychiatry Research
Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics
Ning Lyu, Paul J. Rowan, Susan Abughosh, Tyler Jordan Varisco, Ying Lin, Hua Chen · 2024 · Journal of Child and Adolescent Psychopharmacology
Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls
Hui Fang, Yan Feng Zhen, Xing Yu Liu, Gang Xu, Jair C. Soares, Jingping Zhao, Xiangyang Zhang · 2016 · International Clinical Psychopharmacology
Experimental drugs for bipolar psychosis
Michele Fornaro, Antônio Egídio Nardi, Domenico De Berardis, Mauro Giovanni Carta · 2016 · Expert Opinion on Investigational Drugs
Improving metabolic monitoring rate for young people aged 35 and younger taking antipsychotic medications to treat a psychosis: A literature review
Gin‐Liang Chee, Dianne Wynaden, Karen Heslop · 2017 · Archives of Psychiatric Nursing
Breast Cancer Prevention and Treatment in Women with Severe Mental Illness
Mary Seeman · 2017 · International Journal of Women s Health and Wellness
Framingham coronary score in individuals with symptoms or diagnoses of mental disorders: A review and meta-analysis
Adrien Rigal, Romain Colle, Khalil El Asmar, Céline Elie-Lefebvre, Bruno Falissard, Laurent Becquemont, Céline Verstuyft, Emmanuelle Corruble · 2018 · Psychiatry Research
Oral antipsychotic prescribing and association with neighbourhood-level socioeconomic status: analysis of time trend of routine primary care data in England, 2011–2016
Kurt Buhagiar, Mustafa Ghafouri, Mrinalini Dey · 2019 · Social Psychiatry and Psychiatric Epidemiology
Comparative cardiometabolic risk of antipsychotics in children, adolescents and young adults
Ying-Shan Chung, Shih‐Chieh Shao, Mei-Hong Chi, Swu‐Jane Lin, Chien‐Chou Su, Yea‐Huei Kao Yang, Yen Kuang Yang, Edward Chia‐Cheng Lai · 2020 · European Child & Adolescent Psychiatry
APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients
Wei Li, Fengju Liu, Rui Liu, Xinmei Zhou, Guanjun Li, Shifu Xiao · 2021 · Scientific Reports
Sex-Specific Effect of Serum Lipids and Body Mass Index on Psychotic Symptoms, a Cross-Sectional Study of First-Episode Psychosis Patients
Priyanthi Borgen Gjerde, Carmen Simonsen, Trine Vik Lagerberg, Nils Eiel Steen, Ole A. Andreassen, Vidar Martin Steen, Ingrid S. Melle · 2021 · Frontiers in Psychiatry
Use of Linked Databases for Improved Confounding Control: Considerations for Potential Selection Bias
Jenny W. Sun, Rui Wang, Dongdong Li, Sengwee Toh · 2021 · American Journal of Epidemiology
The benefits of the Mediterranean diet in first episode psychosis patients taking antipsychotics
Εmilia Vassilopoulou, Dimitris Efthymiou, Vasilis Tsironis, Panagiotis Athanasis, Stelios Chatziioannidis, Theano Kesoglou, А.В. Северин, Vasilis P. Bozikas · 2022 · Toxicology Reports
ACO Participation Associated With Decreased Spending For Medicare Beneficiaries With Serious Mental Illness
José F. Figueroa, Jessica Phelan, Helen Newton, Endel John Orav, Ellen R. Meara · 2022 · Health Affairs
Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine
Piaopiao Huang, Wenqiang Zhu, Jingmei Xiao, Yi-Qi Zhang, Rong Li, Yang Yang, Li Shen, Fei Luo, Wen Dai, Pingan Lian et al. · 2022 · Frontiers in Pharmacology
Primary care for individuals with serious mental illness (PriSMI): protocol for a convergent mixed methods study
Agnes Grudniewicz, Allie Peckham, David Rudoler, Miriam Ruth Lavergne, Rachelle Ashcroft, Kimberly M. Corace, Mark Kaluzienski, Ridhwana Kaoser, Lucie Langford, Rita McCracken et al. · 2022 · BMJ Open
Safety and effectiveness of lurasidone in the treatment of Chinese schizophrenia patients: An interim analysis of post-marketing surveillance
Yumei Wei, Xijin Wang, Xiaodong Yang, Chuansheng Wang, Lili Wang, Xiaoying Xu, Guijun Zhao, Bin Li, Daomin Zhu, Qi Wu et al. · 2023 · World Journal of Psychiatry
Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers
Frederik Vandenberghe, Núria Saigí-Morgui, Aurélie Delacrétaz, Lina Quteineh, Séverine Crettol, Nicolas Ansermot, Mehdi Gholam‐Rezaee, Armin von Gunten, Philippe Conus, Chin B. Eap · 2016 · Pharmacogenetics and Genomics
Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances
Aurélie Delacrétaz, Frederik Vandenberghe, Anaïs Glatard, Axel Levier, Céline Dubath, Nicolas Ansermot, Séverine Crettol, Mehdi Gholam‐Rezaee, Idris Guessous, Murielle Bochud et al. · 2018 · Frontiers in Psychiatry
Metabolic and behavioral effects of olanzapine and fluoxetine on the model organism Caenorhabditis elegans
Abdullah Almotayri, Jency Thomas, Mihiri Munasinghe, Maneka Weerasinghe, Deniz Heydarian, Markandeya Jois · 2021 · Saudi Pharmaceutical Journal
Multivalent Approaches and Beyond: Novel Tools for the Investigation of Dopamine D 2 Receptor Pharmacology
Anitha Kopinathan, Peter J. Scammells, J. Robert Lane, Ben Capuano · 2016 · Future Medicinal Chemistry
No Association between Genetic or Epigenetic Variation in Insulin Growth Factors and Antipsychotic-Induced Metabolic Disturbances in a Cross-Sectional Sample
Tim Moons, Marc D. Binder, Gunther Kenis, Wolfgang Viechtbauer, Jim van Os, Henning Gohlke, Stephan J. Claes, Ruud van Winkel · 2014 · Pharmacogenomics
Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine
David E. Kemp, Marc D. Binder, Zia Ur Rahman, P. Fyans, James M. Eudicone, Sabrina Vogel Marler, Ross A. Baker, Berit X. Carlson · 2012 · Journal of Affective Disorders
Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs
Aurélie Delacrétaz, Adna Zdralovic, Frederik Vandenberghe, Núria Saigí-Morgui, Anaïs Glatard, Lina Quteineh, Mehdi Gholam‐Rezaee, Wassim Raffoul, Lee Ann Applegate, Paris Jafari et al. · 2017 · Gene
Increasing Psychiatrists’ Role in Addressing the Cardiovascular Health of Patients With Severe Mental Illness
Martha Ward · 2021 · FOCUS The Journal of Lifelong Learning in Psychiatry
Development of a Symptom-Focused Model to Guide the Prescribing of Antipsychotics in Children and Adolescents: Results of the First Phase of the Safer Use of Antipsychotics in Youth (SUAY) Clinical Trial
Robert B. Penfold, Ella Thompson, Robert J. Hilt, Nadine Schwartz, Adelaide S. Robb, Christoph Ulrich Correll, Douglas A. Newton, Kelly M. Rogalski, Marian F. Earls, Robert A. Kowatch et al. · 2021 · Journal of the American Academy of Child & Adolescent Psychiatry
Long Term Metabolic and Inflammatory Effects of Second-Generation Antipsychotics: A Study in Mentally Disordered Offenders
Εmilia Vassilopoulou, Dimitris Efthymiou, Evangelia Papatriantafyllou, Maria Markopoulou, Efthymia-Maria Sakellariou, Codruța Alina Popescu · 2021 · Journal of Personalized Medicine
Sex differences in antipsychotic-related triglyceride levels are associated with metabolic hormone differences in patients with severe mental disorders
Ingrid Torp Johansen, Nils Eiel Steen, Marit Haram, Linn Nilsen Rødevand, Maren Caroline Frogner Werner, Synve Hoffart Lunding, Gabriela Hjell, Ingrid Agartz, Ingrid S. Melle, Trine Vik Lagerberg et al. · 2022 · Schizophrenia Research
A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia
Andrea L. Schaffer, Joel Chia, Jonathan Brett, Sallie‐Anne Pearson, Michael O. Falster · 2022 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Metoprolol and diltiazem ameliorate ziprasidone-induced prolonged corrected QT interval in rats
Oytun Erbaş, Mustafa Yilmaz · 2013 · Toxicology and Industrial Health
The Legitimacy of Medical Treatment
Donaldson, Cam, Rachel Baker, McHugh, Neil Anthony · 2015 · Routledge eBooks
Bipolar Spectrum Disorders in Male Youth: The Interplay between Symptom Severity, Inflammation, Steroid Secretion, and Body Composition
Andreas Walther, Marlene Sophie Penz, Daniela Ijacic, Timothy Rice · 2017 · Frontiers in Psychiatry
Psychotropic medication profile in a community youth mental health service in Australia
Aprajita Dharni, Dominiek Coates · 2018 · Children and Youth Services Review
Implications of Antipsychotic Use
Sattaria S. Dilks, Rose Mary Xavier, Crystal Marie Kelly, Jessica A. Johnson · 2019 · Nursing Clinics of North America
Childhood trauma and cardiometabolic risk in severe mental disorders: The mediating role of cognitive control
Synve Hoffart Lunding, Carmen Simonsen, Monica Aas, Linn Nilsen Rødevand, Maren Caroline Frogner Werner, Jannicke Fjæra Laskemoen, Gabriela Hjell, Petter Andreas Ringen, Trine Vik Lagerberg, Ingrid S. Melle et al. · 2021 · European Psychiatry
Is Metabolic Syndrome On the Radar?
Kingwai Lui, Gagandeep Randhawa, Vicken Y. Totten, Adam E. Smith, Joachim D. Raese · 2016 · The Primary Care Companion For CNS Disorders
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design
Christian Schmidt-Kraepelin, Sandra Feyerabend, Christina Engelke, Mathias Riesbeck, Eva Meisenzahl‐Lechner, Wolfgang Gäebel, Pablo-Emilio Verde, Henrike Kolbe, Christoph Ulrich Correll, Stefan Leucht et al. · 2019 · European Archives of Psychiatry and Clinical Neuroscience
Metabolic adverse effects of antipsychotics: the state of the problem and management options
Балашова Анастасия Владимировна, Мамлеева Диана Валерьевна, Lubov V. Machekhina, Е. N. Dudinskaya · 2023 · Obesity and metabolism
Evaluating the efficacy of the Thai Health Improvement Profile intervention for preventing weight gain in people with early stage psychosis: A randomized controlled trial
Soontareeporn Meepring, Richard John Gray, Xia Li, Wai Tong Chien, Yan Li, Grace W. K. Ho, Preeyakamon Kritkitrat, Daniel Thomas Bressington · 2023 · International Journal of Nursing Studies
PCSK9 dysregulates cholesterol homeostasis and triglyceride metabolism in olanzapine‐induced hepatic steatosis via both receptor‐dependent and receptor‐independent pathways
Piaopiao Huang, Juanli Ran, Wenqiang Zhu, Wen Dai, Yaxin Tang, Pingan Lian, Xiansheng Huang, Rong Li · 2024 · The FASEB Journal
Exploring the therapeutic potential of chlorogenic acid in alleviating olanzapine-induced metabolic syndrome in rats: a key role of hypothalamic satiety proteins
Zeinab Ebrahimian, Bibi Marjan Razavi, Seyed Ali Mousavi Shaegh, Hossein Hosseinzadeh · 2025 · Nutritional Neuroscience
Connecting the dots: Understanding and addressing the metabolic impact of antipsychotic and antidepressant medications
Susanne U. Miedlich, J. Steven Lamberti · 2025 · Annals of the New York Academy of Sciences
Developing a Sound Body: Open Trial Results of a Group Healthy Lifestyle Intervention for Young Adults with Psychosis
Julia Browne, C. Cather, V. Zvonar, K. Thayer, Hannah E. Skiest, Diana Arntz, Katherine I. Kritikos, K. Schnitzer, H. Brown, A. Evins et al. · 2020 · Community mental health journal
Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study
Mikkel Højlund, Christina Blanner Wagner, Rikke Thaarup Wesselhoeft, Kjeld Andersen, Anders Fink‐Jensen, Jesper Hallas · 2022 · Basic & Clinical Pharmacology & Toxicology
Evolutions of Metabolic Parameters Following Switches of Psychotropic Drugs: A Longitudinal Cohort Study
Marianna Piras, Setareh Ranjbar, Nermine Laaboub, Claire Grosu, Franziska Gamma, Kerstin Jessica Plessen, Armin von Gunten, Philippe Conus, Chin B. Eap · 2022 · Schizophrenia Bulletin
Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer’s Disease
Stephanie M. Perez, Angela M. Boley, Alexandra M. McCoy, Daniel J. Lodge · 2023 · International Journal of Molecular Sciences
Association between degree centrality and neurocognitive impairments in patients with Schizophrenia: A Longitudinal rs-fMRI Study
Shixuan Feng, Yuanyuan Huang, Hongxin Lu, Hehua Li, Sumiao Zhou, Hanna Lu, Yangdong Feng, Yuping Ning, Wei Han, Qing Chang et al. · 2024 · Journal of Psychiatric Research
Lifestyle and mood correlates of cardiometabolic risk in people with serious mental illness on second-generation antipsychotic medications
Susanne U. Miedlich, Priya Sahay, Telva E. Olivares, J. Steven Lamberti, Diane S. Morse, Kevin Brazill, Kavaljit H. Chhabra, Lauren Bainbridge · 2024 · PLoS ONE
Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan
Jacob S. Ballon, René S. Kahn, Christina Arevalo, Martin Dunbar, David McDonnell, Christoph U. Correll · 2024 · The Journal of Clinical Psychiatry
Reduced all-cause mortality with antipsychotics and antidepressants compared to increased all-cause mortality with benzodiazepines in patients with schizophrenia observed in naturalistic treatment settings
José M. Rubio, Christoph U Corell · 2017 · Evidence-Based Mental Health
Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics
Katrine Kveli Fjukstad, Anne Engum, Stian Lydersen, Ingrid Dieset, Nils Eiel Steen, Ole A. Andreassen, Olav Spigset · 2017 · European Psychiatry
Treatment patterns and Medicaid spending in comorbid schizophrenia populations: once-monthly paliperidone palmitate versus oral atypical antipsychotics
Rhiannon L. Kamstra, Dominic Pilon, Patrick Lefèbvre, Bruno Émond, Kruti Joshi · 2018 · Current Medical Research and Opinion
The metabolic effects of antipsychotics in the early stage of treatment in first-episode patients with schizophrenia: A real-world study in a naturalistic setting
Hailing Cao, Yajing Meng, Xiaojing Li, Xiaohong Ma, Wei Deng, Wanjun Guo, Tao Li · 2020 · Journal of Psychiatric Research
CARDIOVASCULAR RISK FACTORS FOR DIFFERENT TYPES OF PSYCHIATRIC PATHOLOGIES. A CORRELATIVE STUDY
G Radu · 2020 · FARMACIA
Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data
Albert Martínez-Pinteño, Patricia Gassó, L. Prohens, Àlex G. Segura, Mara Parellada, Pilar Alejandra Sáiz, Manuel Jesús Cuesta, Miquel Bernardo, Amàlia Lafuente, Sergi Mas et al. · 2021 · Frontiers in Pharmacology
Integrated Review of Lifestyle Interventions Targeting Diet and Exercise in Early or First-Episode Psychosis
Chris Griffiths, Farah Hina · 2021 · Open Journal of Psychiatry
Predictors of Weight Gain and Metabolic Indexes among Men Admitted to Forensic Psychiatric Hospital
N. Zoe Hilton, Elke Ham, Stephanie Hill, Talia Emmanuel, Barna Konkolÿ Thege · 2021 · International Journal of Forensic Mental Health
The association of metabolic syndrome and long acting injectable antipsychotics: A systematic review
Ttk Nguyen, C. McDonald, B. Hallahan · 2022 · European Journal of Psychiatry
Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance
Heidi N. Boyda, Michelle M Pham, Joyce Yongxu Huang, Amanzo A. Ho, Ric M. Procyshyn, Jessica W. Y. Yuen, William G. Honer, Alasdair M. Barr · 2022 · Frontiers in Pharmacology
Should antidiabetic medicines be considered to reduce cardiometabolic risk in patients with serious mental illness?
Kevin Mc Namara, Hamzah Alzubaidi, Margaret Murray, Catarina Samorinha, James Dunbar, Vincent Lawrence Versace, David Jonathan Castle · 2022 · The Medical Journal of Australia
Metformin for Overweight and Obese Children With Bipolar Spectrum Disorders Treated With Second-Generation Antipsychotics (MOBILITY): Protocol and Methodological Considerations for a Large Pragmatic Randomized Clinical Trial
Jeffrey A. Welge, Christoph Ulrich Correll, Michael T. Sorter, Victor Fornari, Thomas J. Blom, Adam C. Carle, Bin Huang, Christina C. Klein, Melissa P. DelBello · 2023 · JAACAP Open
Dysmetabolic features of the overweight patients receiving antipsychotic drugs: A comparison with normal weight and obese subjects
Peter Manu, Christoph Ulrich Correll, Martien Wampers, Ruud van Winkel, W. Yu, Daphna Shiffeldrim, M.A.F. De Hert · 2013 · European Psychiatry
Psychometric properties of the Spanish version of the Body Weight, Image and Self-Esteem Evaluation questionnaire in patients with severe mental disorders
Susana Al‐Halabí, María Paz García‐Portilla, Pilar Alejandra Sáiz, Eduardo Fonseca‐Pedrero, Teresa Bobes-Bascarán, Gonzalo Galván, Celso Iglesias García, Manuel Arrojo, Antoni Benabarre, José Manuel Goikolea et al. · 2012 · Comprehensive Psychiatry
Pharmacological Treatment for Long-Term Patients with Schizophrenia and Its Effects on Sleep in Daily Clinical Practice: A Pilot Study
Peggy Bosch, Sabina Lim, Heike Staudte, Sujung Yeo, Sook‐Hyun Lee, Pia Barisch, Benoît Perriard, Maurits van den Noort · 2018 · Medicines
A best‐worst scaling experiment to identify patient‐centered claims‐based outcomes for evaluation of pediatric antipsychotic monitoring programs
Thomas I. Mackie, Katherine M. Kovacs, Cassandra Simmel, Stephen Crystal, Sheree Neese‐Todd, Ayşe Akıncıgil · 2020 · Health Services Research
Insulin Resistance–Related Proteins Are Overexpressed in Patients and Rats Treated With Olanzapine and Are Reverted by Pueraria in the Rat Model
Ni Yang, Shihong Li, Shouqing Liu, Yifan Lv, Liangyu Yu, Yahui Deng, Huqun Li, Maosheng Fang, Yunxiang Huo, Weiyong Li et al. · 2019 · Journal of Clinical Psychopharmacology
Acanthosis Nigricans During Treatment With Aripiprazole
Peter Manu, Zainab Al-Dhaher, Navin Dargani, Christoph Ulrich Correll · 2012 · American Journal of Therapeutics
Effect of Supplementation with Probiotics in Patients with Schizophrenia: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Li, Lu, Du, Fengqi, Liu, Xilong, Song, Mengyao, Grosso, Giuseppe, Battino, Maurizio, Boesch, Christine, Li, He, Liu, Xinqi · 2025 · Foods
Recommendations for the medical work‐up of first episode psychosis, including specific relevance to Indigenous Australians: A narrative review
Kiernan Dorney, Michael Murphy · 2020 · Early Intervention in Psychiatry
Deep retinal layer microvasculature alterations in schizophrenia
Samantha I. Fradkin, Deepthi Bannai, Paulo L. Lizano, Adriann Lai, Christen M. Crosta, Judy L. Thompson, Steven M. Silverstein · 2024 · Biomarkers in Neuropsychiatry
Prevalence and predictors of metabolic syndrome among psychiatric patients receiving antipsychotic treatment in Africa: a systematic review and meta-analysis
Mulualem Admasu Kelebie, Getasew Kibralew, Gebresilassie Tadesse, Girum Nakie, Dawed Ali, Biruk Fanta, Mulu Muche, Setegn Fentahun, Gidey Rtbey, Girmaw Medfu Takelle · 2025 · BMC Psychiatry
Prevalence of metabolic syndrome in Chinese patients with schizophrenia: a systematic review and meta-analysis
Liping Feng, Guoli Yan, Mengmei E. Wang, Tong Lei, Ling Sun, Tianhong Zhou · 2025 · BMC Psychiatry
Depressed mood and suicidal thoughts reporting with GLP-1 receptor agonists in type 2 diabetes: A WHO VigiBase study
Mohammed Aboukaoud, Bosmat Hoch, Mark Weiser, Revital Amiaz · 2026 · Journal of Affective Disorders
Rapid Adipose Deposition with Mood Disorders
Jess G. Fiedorowicz, Lorick E. Andersen, Jane E. Persons, Chadi Albert Calarge · 2015 · Annals of Clinical Psychiatry
Mens sana in corpore sano : l’intérêt de l’activité physique auprès des jeunes ayant eu un premier épisode psychotique
Ahmed Jérôme Romain, Paquito Bernard, Florence Piché, Laurence Kern, Clairélaine Ouellet‐Plamondon, Amal Abdel‐Baki, Marc‐André Roy · 2021 · Santé mentale au Québec
Effects of Combined Therapy of Olanzapine and Samidorphan on Safety and Metabolic Parameters in Schizophrenia Patients: A Meta-Analysis
Zhenlei Peng, Qiyu Jia, Junxiong Mao, Qizhong Yi · 2023 · Neuropsychiatric Disease and Treatment
Association of accelerated aging with the incidence risk of Cardiometabolic diseases in people with severe mental illnesses: A prospective analysis in UK Biobank
Chengcheng Zhang, Zhen Ling, Xiang Qin Lin, Yang Zhang, Ling Li, Songchun Yang, Yi Xiao, Minxue Shen, Shuiyuan Xiao · 2024 · Psychiatry Research
Glucose monitoring in new users of second-generation antipsychotics in older people
Henry C. Ndukwe, Prasad S. Nishtala · 2017 · Archives of Gerontology and Geriatrics
Getting to precision psychopharmacology: Combining clinical and genetic information to predict fat gain from aripiprazole
Hanadi Ajam Oughli, Eric J. Lenze, Adam E. Locke, Michael D. Yingling, Yongqi Zhong, J. Philip Miller, Charles F. Reynolds, Benoit H. Mulsant, John W. Newcomer, Timothy R. Peterson et al. · 2019 · Journal of Psychiatric Research
The Case for Case Management in Schizophrenia
Rif S. El‐Mallakh, T. Patrick Rhodes, Katharine Dobbins · 2019 · Professional Case Management
How to Estimate QT Interval in Patients With Left or Right Bundle Branch Block
Kristian Fredholm, Mikkel Højlund, Mads Rye Bjerregaard, Jens Cosedis Nielsen, Anders Fink‐Jensen, Christoph Ulrich Correll · 2021 · Journal of Clinical Psychopharmacology
Assessment of Protective Effects of Carvacrol on Haloperidol-Induced Oxidative Stress and Genotoxicity in Human Peripheral Blood Lymphocytes
Ehsan Zamani, Alireza Ahmadi Shad, Hediye Fatemi, Saba Mahboubi, Azadeh Motavallian, Mehdi Evazalipour · 2022 · Journal of Toxicology
Pharmacological interventions for reducing weight gain in schizophrenia
Margaret Hahn, Gary J. Remington, Markus J. Duncan, Tony A. Cohn, Guy Faulkner · 2014 · Cochrane Database of Systematic Reviews
Arterial Hypertension and Posterior Reversible Cerebral Edema Syndrome Induced by Risperidone
Gregorio Paolo Milani, Mario Giovanni Bianchetti, Marta Benedetta Maria Mazzoni, Fabio Maria Triulzi, Massimo Carlo Mauri, Carlo Virginio Agostoni, Emilio Filippo Fossali · 2014 · PEDIATRICS
Andere spezifische Diabetesformen und exokrine Pankreasinsuffizienz (Update 2019)
Susanne Kaser, Yvonne Winhofer-Stöckl, Lili Kazemi-Shirazi, Sabine E. Hofer, Helmut Brath, Harald Sourij, Greisa Vila, Heidemarie Abrahamian, Michaela Riedl, Raimund Weitgasser et al. · 2019 · Wiener klinische Wochenschrift
Development of a mortality score to assess risk of adverse drug reactions among hospitalized patients with moderate to severe chronic kidney disease
Monica Danial, Mohamed Azmi Hassali, Ong Loke Meng, Yoon Chee Kin, Amer Hayat Khan · 2019 · BMC Pharmacology and Toxicology
Unmet challenges in treating hypertension in patients with borderline personality disorder
Saara M. Roininen, Marcus Cheetham, Beatrice U. Mueller, Edouard J. Battegay · 2019 · Medicine